These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 25663298)
1. Clinico-pathological factors influencing lymph node yield in colorectal cancer and impact on survival: analysis of New Zealand Cancer Registry data. Ahmadi O; Stringer MD; Black MA; McCall JL J Surg Oncol; 2015 Mar; 111(4):451-8. PubMed ID: 25663298 [TBL] [Abstract][Full Text] [Related]
2. Influence of age and site of disease on lymph node yield in colorectal cancer. Ahmadi O; Stringer MD; Black MA; McCall JL N Z Med J; 2014 Jun; 127(1395):31-40. PubMed ID: 24929691 [TBL] [Abstract][Full Text] [Related]
3. Role of lymph node yield and lymph node ratio in predicting outcomes in non-metastatic colorectal cancer. Lee CHA; Wilkins S; Oliva K; Staples MP; McMurrick PJ BJS Open; 2019 Feb; 3(1):95-105. PubMed ID: 30734020 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of lymph node ratio in stage III colorectal cancer. Wong KP; Poon JT; Fan JK; Law WL Colorectal Dis; 2011 Oct; 13(10):1116-22. PubMed ID: 20874800 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Leggett MD; Chen SL; Schneider PD; Martinez SR Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930 [TBL] [Abstract][Full Text] [Related]
6. Quantitative lymph node evaluation as an independent marker of long-term prognosis in stage III rectal cancer. Vather R; Sammour T; Kahokehr A; Connolly A; Hill A ANZ J Surg; 2011 Dec; 81(12):883-8. PubMed ID: 22507414 [TBL] [Abstract][Full Text] [Related]
8. Lymph node ratio prognosticates overall survival in patients with stage IV colorectal cancer. Naidu K; Chapuis PH; Connell L; Chan C; Rickard MJFX; Ng KS Tech Coloproctol; 2024 Aug; 28(1):115. PubMed ID: 39177674 [TBL] [Abstract][Full Text] [Related]
9. Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy. Xu Z; Berho ME; Becerra AZ; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JRT; Fleming FJ J Clin Pathol; 2017 Jul; 70(7):584-592. PubMed ID: 27932667 [TBL] [Abstract][Full Text] [Related]
10. Tumour stage and preoperative chemoradiotherapy influence the lymph node yield in stages I-III rectal cancer: results from a prospective nationwide cohort study. Lykke J; Roikjaer O; Jess P; Colorectal Dis; 2014 Apr; 16(4):O144-9. PubMed ID: 24329928 [TBL] [Abstract][Full Text] [Related]
11. Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer. Kotake K; Honjo S; Sugihara K; Hashiguchi Y; Kato T; Kodaira S; Muto T; Koyama Y Jpn J Clin Oncol; 2012 Jan; 42(1):29-35. PubMed ID: 22102737 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Rosenberg R; Engel J; Bruns C; Heitland W; Hermes N; Jauch KW; Kopp R; Pütterich E; Ruppert R; Schuster T; Friess H; Hölzel D Ann Surg; 2010 Jun; 251(6):1070-8. PubMed ID: 20485149 [TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio is a significant predictor of disease-specific mortality in patients undergoing esophagectomy for cancer. Fox M; Farmer R; Scoggins CR; McMasters KM; Martin RC Am Surg; 2012 May; 78(5):528-34. PubMed ID: 22546123 [TBL] [Abstract][Full Text] [Related]
14. [Impact of number of retrieved lymph nodes and lymph node ratio on the prognosis in patients with stage II and III colorectal cancer]. Shao XL; Han HQ; He XL; Fu Q; Lv YC; Liu G Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Apr; 14(4):249-53. PubMed ID: 21538264 [TBL] [Abstract][Full Text] [Related]
15. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years. Akagi Y; Adachi Y; Ohchi T; Kinugasa T; Shirouzu K Anticancer Res; 2013 Jul; 33(7):2965-70. PubMed ID: 23780987 [TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of lymph node ratio in survival of patients with stage III rectal cancer]. Zhu XW; Wu CS; Yuan SC Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):506-9. PubMed ID: 22967468 [TBL] [Abstract][Full Text] [Related]
18. A novel data-driven prognostic model for staging of colorectal cancer. Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905 [TBL] [Abstract][Full Text] [Related]
19. Aspects of survival from colorectal cancer in Denmark. Iversen LH Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726 [TBL] [Abstract][Full Text] [Related]
20. Time-dependent trends in lymph node yield and impact on adjuvant therapy decisions in colon cancer surgery: an international multi-institutional study. Stojadinovic A; Nissan A; Wainberg Z; Shen P; McCarter M; Protic M; Howard RS; Steele SR; Peoples GE; Bilchik A Ann Surg Oncol; 2012 Dec; 19(13):4178-85. PubMed ID: 22805869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]